GLP1R and type 2 diabetes mellitus: Table 1 presents the distribution of demographic and clinical characteristics among obese adults with type 2 diabetes, stratified by GLP-1 agonist (exenatide) prescription status, based on weighted estimates from the NAMCS for 2010-2015.